TAS6417/CLN-081 Is a Pan-Mutation–Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations
2019 ◽
Vol 17
(11)
◽
pp. 2233-2243
◽
2011 ◽
Vol 10
(6)
◽
pp. 1102-1112
◽